Clinical trial
Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne Vulgaris
NCT02525549 is registered in ClinicalTrials.gov with Padagis LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne Vulgaris
- Lead sponsor
- Padagis LLC
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2011
- Completion date
- August 31, 2012
- Enrollment
- 903 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acne